Quick-Trials for Novel Cancer Therapies: Exploratory Grants
This PA replaces PAR-03-005.
This Program Announcement (PA) is intended to provide investigators with rapid access to support for pilot, phase I, and phase II cancer clinical trials as well as support for patient monitoring and laboratory studies linked to a cancer clinical trial. The focus of this QUICK-TRIAL PA is on translational research in new agent development to ensure the timely exploitation of new cancer therapeutic approaches including the development of new cancer prevention agents.
This PA will use the NIH exploratory/development (R21) award mechanism.
For more information see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=2220. Inquiries: Dr. Roy Wu, firstname.lastname@example.org
Bioengineering Approaches to Energy Balance and Obesity (SBIR/STTR)
The purpose of this PA is to solicit applications to develop and validate new and innovative bioengineering technology to address clinical problems related to energy balance, intake, and expenditure. Novel sensors, devices, imaging, and other approaches are expected to be developed and evaluated by collaborating engineers, physical scientists, and scientists from other relevant disciplines with expertise in obesity and nutrition. The goal is to increase the number of useful technologies and tools available to scientists to facilitate their research in energy balance and health.
This PA uses the SBIR and STTR mechanisms, which are set-aside programs.
For more information see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=2241. Inquiries: Dr. Sharon Ross, email@example.com; Dr. Connie Dresser, firstname.lastname@example.org; Dr. Audie A. Atienza, email@example.com